Variant report
Variant | nsv969216 |
---|---|
Chromosome Location | chr5:30269748-30277411 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs550970187 | chr5:30271419-30271420 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs76804735 | chr5:30271500-30271501 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs146380030 | chr5:30271503-30271504 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs530946279 | chr5:30271544-30271545 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs544666747 | chr5:30271588-30271589 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs185575054 | chr5:30271619-30271620 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs4626349 | chr5:30271639-30271640 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
8 | rs369279770 | chr5:30271767-30271768 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs200144976 | chr5:30271768-30271769 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs546824496 | chr5:30271792-30271793 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs567147620 | chr5:30271809-30271810 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs529571106 | chr5:30271819-30271820 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs547767032 | chr5:30271828-30271829 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs567006987 | chr5:30271830-30271831 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs567682781 | chr5:30271961-30271962 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs73089235 | chr5:30271967-30271968 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
17 | rs148584836 | chr5:30272008-30272009 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs570494353 | chr5:30272014-30272015 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs76810232 | chr5:30272033-30272034 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs34885267 | chr5:30272143-30272144 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs552923350 | chr5:30272212-30272213 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs573161244 | chr5:30272222-30272223 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs142995058 | chr5:30272332-30272333 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs555722382 | chr5:30272394-30272395 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs182104739 | chr5:30272409-30272410 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs151031575 | chr5:30272417-30272418 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs564593128 | chr5:30272459-30272460 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs555606499 | chr5:30272504-30272505 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs533308381 | chr5:30272553-30272554 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs540798657 | chr5:30272609-30272610 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs375987126 | chr5:30272643-30272644 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs111354108 | chr5:30272667-30272668 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs575554194 | chr5:30272726-30272727 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs529460060 | chr5:30272753-30272754 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs188963276 | chr5:30272833-30272834 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs193247210 | chr5:30272856-30272857 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs183585765 | chr5:30272857-30272858 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs34076177 | chr5:30272885-30272886 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs557316001 | chr5:30272887-30272888 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs577608211 | chr5:30272917-30272918 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs570505470 | chr5:30272918-30272919 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs139706269 | chr5:30272919-30272920 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs553050996 | chr5:30272927-30272928 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs566645040 | chr5:30272931-30272932 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs369629747 | chr5:30272948-30272949 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs535651079 | chr5:30272951-30272952 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs555657460 | chr5:30273018-30273019 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs575648965 | chr5:30273022-30273023 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs544588872 | chr5:30273023-30273024 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs557891572 | chr5:30273037-30273038 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Cervical squamous cell carcinoma | 21590768 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Liposarcoma | 21253554 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Cervical Cancer | 21857958 | CNVD |
Cervical cancer | 21062161 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Oral cancer | 21386901 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Cervical cancer | 18559093 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Gastric cancer | 22152101 | CNVD |
Oesophago-gastric ulcer | 22152101 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Multiple myeloma | 17550852 | CNVD |
prenatal diagnosis | 22389664 | CNVD |
Bladder cancer | 21909424 | CNVD |
DNA damage stimulus | 22844521 | CNVD |
DNA repair | 22844521 | CNVD |
Breast cancer | 21785460 | CNVD |
Spinal muscular atrophy | 22422766 | CNVD |
Spinal muscular atrophy | 22558076 | CNVD |
Spinal muscular atrophy | 21320981 | CNVD |
Spinal muscular atrophy | 21762474 | CNVD |
Breast cancer | 21858162 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Cancer | 16751803 | CNVD |
Breast cancer | 16608533 | CNVD |
Autism | 22495311 | CNVD |
Melanoma | 18172304 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Intellectual disability | 22102821 | CNVD |
Prostate cancer | 21965145 | CNVD |
Cancer | 21183584 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Breast cancer | 17603634 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Non-small cell lung cancer | 19010865 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Compulsive disorder | 18923513 | CNVD |
Epilepsy | 18923513 | CNVD |
Prader-willi syndrome | 18923513 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Lung cancer | 18438408 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Glioma | 20126413 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Breast cancer | 22032731 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21364760 | CNVD |
Breast cancer | 20409316 | CNVD |
Medulloblastoma | 19270706 | CNVD |
Breast cancer | 19553991 | CNVD |
Lung cancer | 19553991 | CNVD |
Melanoma | 19553991 | CNVD |
Ovarian cancer | 19553991 | CNVD |
Prostate cancer | 19553991 | CNVD |
Non-small cell lung cancer | 17156491 | CNVD |
Breast cancer | 17133270 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Schizophrenia | 18923514 | CNVD |
Schizophrenia | 22241247 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:30271400-30274400 | Enhancers | Hela-S3 | cervix |
2 | chr5:30276200-30276600 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
3 | chr5:30276400-30277000 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |